VendevAegen 89
Danderyd 182 32
Sweden
46 8 12 40 52 00
https://www.sedanamedical.com
Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 88
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Johannes Doll | CEO & Pres | 5.33M | N/A | 1981 |
Mr. Johan G. Spetz | Chief Financial Officer | N/A | N/A | 1984 |
Mr. Peter Froberg | Chief Technology Officer | N/A | N/A | 1971 |
Ms. Karolina Vilval L.L.M. | Gen. Counsel | N/A | N/A | 1979 |
Clarisa Mogollón | Head of Marketing | N/A | N/A | N/A |
Mr. Peter Sackey M.D., Ph.D. | Chief Medical Officer | N/A | N/A | 1971 |
Linda Frölén | Head of Group Fin. | N/A | N/A | N/A |
Anders Ersson | Head of International Markets | N/A | N/A | 1969 |
Sedana Medical AB (publ), a medical technology company, develops, markets, and sells medical devices in Sweden and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-, which are disposable medical devices that enables the administration of volatile anesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and FlurAbsorb mount to hold the filter during scavenging of anesthetic gas. It also provides AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and various accessories comprising DRYLINE II Water Traps, WaterLock 2 water trap, Nafion Dryer Tubing, and Respiratory Gas Monitoring Line. Sedana Medical AB (publ) was founded in 1999 and is headquartered in Danderyd, Sweden.
Sedana Medical AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.